HeraMED Ltd
HMD
Company Profile
Business description
HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.
Contact
201, 697 Burke Road
Suite 4
CamberwellVIC3124
AUST: +61 272511888
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,637.50 | 22.80 | -0.26% |
| CAC 40 | 7,737.20 | 14.69 | -0.19% |
| DAX 40 | 23,930.67 | 66.81 | -0.28% |
| Dow JONES (US) | 42,173.80 | 96.27 | -0.23% |
| FTSE 100 | 8,774.26 | 1.88 | 0.02% |
| HKSE | 23,157.97 | 131.80 | -0.57% |
| NASDAQ | 19,199.05 | 85.29 | 0.45% |
| Nikkei 225 | 37,470.67 | 494.43 | -1.30% |
| NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
| S&P 500 | 5,919.22 | 7.53 | 0.13% |
| S&P/ASX 200 | 8,414.10 | 20.60 | -0.24% |
| SSE Composite Index | 3,347.49 | 15.96 | -0.47% |